To achieve this, we introduced lentiviral sgRNAs targeting either Impdh1, Impdh2, or Rosa26 into LSCs isolated from MLL-AF9-driven AML generated from Cas9-inducible mice30. This evidence concerns the gene KMT2A and acute myeloid leukemia.